NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
IBDIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/16/2026
Trademark type
Word
Nice classes
44
Filing date
06/04/2024
Registration date
06/16/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-05-00
First use in commerce
2024-05-00
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Takeda Pharmaceuticals U.S.A., Inc.
Representatives
Karl M. Zielaznicki, Esq. Troutman Pepper Locke LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about inflammatory bowel disease (IBD) and pharmaceutical treatment thereof
Publications
History of USPTO decisions and trademark events.
25 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/27/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/18/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/18/2026
IUAF
USE AMENDMENT FILED
11/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/17/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2024
GNRT
NON-FINAL ACTION E-MAILED
12/20/2024
CNRT
NON-FINAL ACTION WRITTEN
12/20/2024
DOCK
ASSIGNED TO EXAMINER
12/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2024
NWAP
NEW APPLICATION ENTERED
06/04/2024
Continuous trademark protection
Get notified about every new filing that threatens IBDIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.